Anti-Human CD11a Therapeutic Antibody (Odulimomab)

Recombinant monoclonal antibody to CD11a. Odulimomab is an investigational drug for the prevention of transplant rejection and for the treatment of various immunological diseases. It is a mouse monoclonal antibody directed against the alpha chain of the protein lymphocyte function-associated antigen 1 which is involved in immune reactions.
Supplier Creative Biolabs
Product # TAB-108
Pricing Inquiry
Host Mouse
Target CD11a
Species Reactivity Human
Type IgG1
Applications Suitable for use in Neut, ELISA, IF, IP, FuncS, FC, ICC and most other immunological methods.
Storage Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples.
Feedback